---
title: The Effects of Resveratrol Supplementation on Measurements of Health and Human Performance
nct_id: NCT01244360
overall_status: UNKNOWN
phase: NA
sponsor: Marywood University
study_type: INTERVENTIONAL
primary_condition: Inflammation
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01244360.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01244360"
ct_last_update_post_date: 2011-06-02
last_seen_at: "2026-05-12T06:09:51.485Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# The Effects of Resveratrol Supplementation on Measurements of Health and Human Performance

**NCT ID:** [NCT01244360](https://clinicaltrials.gov/study/NCT01244360)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 44
- **Lead Sponsor:** Marywood University
- **Conditions:** Inflammation
- **Start Date:** 2010-11
- **Completion Date:** 2011-06
- **CT.gov Last Update:** 2011-06-02

## Brief Summary

The purpose of this study is to examine the effects of resveratrol on health and human performance. The study will evaluate cognitive function and several indicators of physical health before and after taking a resveratrol supplement or a placebo for three weeks.

## Detailed Description

Measurements

* blood laboratory parameters
* cognitive assessment changes
* body composition changes
* vascular endothelial response

## Eligibility

- **Minimum age:** 45 Years
- **Maximum age:** 75 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* men and women between 45 and 75 years of age
* Normal heart rate and Blood pressure
* Ability to use personal computer interface
* Successful completion of physical activity readiness questionnaire

Exclusion Criteria:

* Cardiovascular disease, uncontrolled hypertension, lung disease
* inability to tolerate exercise
* have taken grape related supplement in past 12 months
* current use of drugs or dietary supplements to enhance exercise performance
* allergy to wine, grape juice or grape seed supplements
```

## Arms

- **Sugar Pill** (PLACEBO_COMPARATOR) — Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.
- **Dietary Supplement: resveratrol** (ACTIVE_COMPARATOR) — Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.

## Interventions

- **resveratrol** (DIETARY_SUPPLEMENT) — Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.
- **Placebo Comparator: Sugar Pill** (OTHER) — Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.

## Primary Outcomes

- **Vascular function** _(time frame: 4 weeks, with option of additional 4 week treatment period)_ — vascular response to stress will be measured using flow mediated dilation and ultrasound.

## Secondary Outcomes

- **Body fat percentage** _(time frame: 4 weeks, with optional additional 4 week treatment period)_
- **inflammation biomarkers** _(time frame: 4 weeks, with optional additional 4 week treatment period)_
- **cognitive function** _(time frame: 4 weeks, with optional additional 4 week treatment period)_

## Locations (1)

- Marywood University, Scranton, Pennsylvania, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.marywood university|scranton|pennsylvania|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01244360.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01244360*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*